US industry signs up to disaster task force
This article was originally published in Clinica
AdvaMed has joined the joint task force on disaster readiness, which will focus on supply chain management issues facing the delivery of medical products during national emergencies.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.